Home » Topics » Briefs » Other news to note

Other news to note
RSS

Elan consolidates U.K. and Irish subsidiaries

Oct. 23, 1997

Corvas: Q3 1997 highlights

Oct. 23, 1997

Elan: Q3 1997 highlights

Oct. 23, 1997

Merck & Co.: Q3 1997 highlights

Oct. 22, 1997

Eisai: Annual Report 1997

Oct. 22, 1997

RTP Pharma and Elan create company dedicated to ciclosporin development

Oct. 21, 1997

Isis Pharmaceuticals: HY 1997 highlights

Oct. 21, 1997

The Immune Response Corporation: HY 1997 highlights

Oct. 21, 1997

Products under development at Meiji Seika

Oct. 20, 1997

New cell therapy company to be formed by VIMRx and Baxter

Oct. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...